InvestorsHub Logo
Post# of 251605
Next 10
Followers 827
Posts 119484
Boards Moderated 15
Alias Born 09/05/2002

Re: DewDiligence post# 207431

Tuesday, 01/24/2017 10:03:11 AM

Tuesday, January 24, 2017 10:03:11 AM

Post# of 251605
JNJ 4Q16 sales increased 7.6% YoY—if you exclude several things:

http://finance.yahoo.com/news/johnson-johnson-reports-2016-fourth-114000089.html

As a reminder, there were additional shipping days in the fourth quarter of 2015 that negatively impacted the current quarter by 480 basis points. Excluding the net impact of acquisitions, divestitures, hepatitis C, Venezuela, and the additional shipping days in 2015, on an operational basis [i.e. excluding currency swings], worldwide sales increased 7.6%...

Without the above exclusions, 4Q16 sales increased 1.7%.

4Q16 Imbruvica sales increased 47% YoY to $346M.

CC slides:
http://www.investor.jnj.com/common/download/download.cfm?companyid=JNJ&fileid=924927&filekey=15D6B809-FBF4-4096-AFE2-1D1DD7BAF825&filename=JNJ_Earnings_Presentation_4Q2016.pdf

Sales of leading products:
http://www.investor.jnj.com/common/download/download.cfm?companyid=JNJ&fileid=924677&filekey=ACE5F259-F6F1-4BB2-9D09-1075DD7F6E9C&filename=Sales_of_Key_Products_Franchises_4Q2016.pdf

JNJ is trading -2% as I’m typing.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.